Objectives. SSc patients are recognized as presenting an increased risk of altered bone mass. The aim of this study was to assess the bone quality, by trabecular bone score (TBS), in SSc patients in correlation with different levels of microvascular damage, as evaluated by nailfold videocapillaroscopy (NVC), and to compare the results regarding bone quality with RA patients and healthy subjects (CNT).
Introduction
Osteoporosis (OP) is a progressive systemic disease, characterized by low bone mass and microarchitecture deterioration of the bone tissue, with a consequent increase in bone fragility and fracture risk. Treatment of this disease often necessitates a multidisciplinary approach [13] .
OP may be classified as either primary or secondary. Primary OP is bone loss associated with the ageing process in both men and women. Although the rate of activation of skeletal bone remodelling units in primary OP is normal, the filling of bone resorption pits is incomplete. Secondary OP is bone loss due to a variety of chronic medical conditions, such as medication effects or nutritional deficiencies. Most types of secondary OP show an increase in the activation rate of skeletal bone remodelling units at least initially, to such an extent that an increased proportion of the skeleton is undergoing remodelling at any one time [13] .
Several studies have demonstrated that patients with rheumatic inflammatory diseases present an increased risk of low bone mass [4, 5] . In rheumatic diseases, for example SSc and RA, the aetiology of bone loss is multifactorial, resulting from disability, age, longstanding diseases, low BMI, chronic systemic inflammation and low vitamin D serum concentrations [612] .
SSc is a chronic autoimmune CTD, characterized by microvascular damage and progressive fibrosis of the skin and internal organs [13] . The severity of the microvascular impairment might be quantified by nailfold videocapillaroscopy (NVC) patterns [1416] . It has been reported that there is a higher incidence of OP and bone fractures in SSc patients than in healthy controls [17, 18] . RA is commonly associated with secondary OP, but has recently been taken into account also as an independent risk factor in the assessment of bone fracture risk [19, 20] .
In 1994, the WHO established operational definitions of OP and osteopenia in postmenopausal white women based on BMD to help researchers and clinicians to classify degrees of bone loss. Currently, the clinical practice gold standard for the diagnosis of OP, including secondary causes, is the analysis of BMD with DXA [2123] . There are different limitations in BMD sensitivity, for example BMD takes into account both trabecular and cortical compartments and does not detect all of the factors that contribute to bone strength, such as bone quality [2123] . In the past few years several studies have demonstrated that the bone microarchitecture plays a determinant role in bone strength. The trabecular bone score (TBS) was developed to meet the need for an index able to assess bone microarchitecture. TBS is based on standard DXA images and provides additional skeletal information to the standard BMD results [24, 25] . The TBS provides an indirect measurement of bone axial microarchitecture and bone quality since cancellous bone microarchitecture cannot be measured by DXA [24, 25] .
This study aimed to assess bone mass and bone quality in female postmenopausal patients affected by SSc in comparison with a high-risk population affected by RA and a control group, by evaluating the TBS. To the best of our knowledge, this is the first study to evaluate the use of TBS in SSc patients with different nailfold videocapillaroscopy (NVC) pattern.
Methods

Study population
Eighty-four SSc patients [mean age 65 (9) years] and 98 RA patients [mean age 61 (8) years] were enrolled, during routine clinical assessment in our Rheumatology Department from January 2013 to November 2016. Sixty healthy controls [mean age 64 (11) years] were also evaluated. All subjects with SSc, RA and CNT were women in the postmenopausal period (see Table 1 ). The SSc patients met either LeRoy's criteria for the classification of early SSc or the ACR/EULAR 2013 criteria for SSc [26, 27] .
The severity of skin involvement was quantified by the modified Rodnan skin score in each SSc patient and was used to differentiate the two principal subsets of skin involvement, that is lcSSc confined to face and extremities and dcSSc [28] . All the RA patients fulfilled the ACR/ EULAR 2010 criteria for RA [29] .
A complete medical history was collected and a clinical examination was performed for all study participants. Demographic data, such as age, gender, height, weight and BMI, were recorded for all subjects. All patients were not affected by secondary causes of OP, such as metabolic and endocrinological diseases or drug-induced OP. The data reported in our retrospective study were obtained during routine clinical imaging examinations performed in clinical practice, and therefore no ethical approval was necessary. We obtained patients' written informed consent to use their imaging pictures and the demographic data as educational material and for publications.
The inclusion criteria were patients with a diagnosis of SSc or RA; all patients presenting to our Department are usually given routine OP screening during evaluation. Moreover, all patients had been on a stable drug regimen for at least 2 months prior to study entry. The exclusion criteria were being on a drug regimen that could potentially influence bone turnover such bisphosphonate, and dosage of glucocorticoid (prednisone equivalent) 57.5 mg/day.
The patients' history included information about vertebral and non-vertebral fractures assessed with lateral spinal radiographs of the thoracic and lumbar spine and other areas when possible. BMD X-ray absorptiometry (DXA scan, Lunar Prodigy, GE Lunar, Madison, WI, USA) was used to obtain BMD (g/cm 2 ) in all SSc and RA patients, as well as in controls. Both lumbar spines (L1L4) and the left hip (femoral neck, Ward's triangle, trochanter, total hip) were examined and the instruments were calibrated daily, according to the manufacturer's instructions. The weight, height, age and gender of each patient were used to estimate BMD (expressed as g/cm 2 with S.D.) and compared with the BMD values of controls. BMD values were expressed as a T-score, which shows the amount of bone present compared with a young adult of the same gender with peak bone mass [2123] . A score above À1 is considered normal in BMD T-scores obtained at the femur and lumbar spine, a score between À1 and À2.5 is classified as osteopenia (low bone mass) and a score below À2.5 is defined as OP. We also calculated the Z-score. This number reflects the amount of bone present compared with other people in the same age group, of the same size and gender. If this score is unusually high or low, further medical tests may be advisable [2123] .
TBS
The TBS is a relatively new tool that allows for evaluation of the bone microarchitecture through the acquisition and https://academic.oup.com/rheumatology measurement of the pixel variations that correspond to the attenuation of the X-ray beam of each single point represented by greyscale images in the DXA of the lumbar spine. The variations in the greyscale measured on DXA 2D images reflect the absorption property variations that are characteristic and the different microarchitectural 3D conformations of the trabecular tissue, allowing for a direct comparison with the BMD score and application to existing datasets [23, 24] . Although TBS is not a direct measurement of bone microarchitecture, it is related to 3D bone characteristics, such as the trabecular number, trabecular separation, connectivity density and Parfitt parameters [23, 24, 3032] .
A steep variogram slope with a high TBS value is associated with better bone structure, whereas low TBS values indicate a worse bone structure. TBS is typically measured at the lumbar spine and is determined by using the same region of interest as the BMD measurement, so that vertebrae excluded from the BMD calculation, for example vertebrae with fractures or OA, are also excluded from the TBS analysis. Although the TBS result is given for each vertebra, the TBS value reported represents the average of L1L4 [23, 24, 3032] . Vertebrae are mainly constituted of trabecular bone.
A normal range for TBS values in postmenopausal women has been proposed: a TBS of 1.350 or more is considered normal; a TBS between 1.200 and 1.350 is considered consistent with partially degraded microarchitecture and a TBS of 1.200 or less defines degraded microarchitecture. These cutoff points were established by analogy with the three BMD categories, that is normal bone mass, osteopenia and OP. Interestingly, a normal range for TBS in men has not yet been proposed [23, 24, 3032] .
The lumbar spine L1L4 TBS was calculated on each spine DXA examination blinded to clinical parameters and outcomes using TBS iNsight (Medimaps Group/GE Healthcare Needham, MA, USA, software version 2.1.0.0) [23, 24, 3032] .
As mentioned, TBS is a grey-level measure of texture using a modified experimental variogram that can be extracted from DXA images and provides an indirect measurement of bone axial microarchitecture and information on bone quality [19, 22] . The manufacturer's crosscalibration for TBS was on each device before the software was installed. TBS is a texture analysis parameter correlated to the bone microarchitecture Parfitt parameters [23, 24, 3032] . 
NVC
In order to place the SSc patients into groups according to the correct microangiopathy pattern (early, active or late), as previously reported by Cutolo and colleagues [1416, 33, 34] , NVC was performed using an optical probe equipped with a Â200 contact lens, connected to image analysis software (Videocap, DS Medica, Milan, Italy). There were 18 SSc patients with an early, 18 with an active and 48 with a late NVC pattern.
Statistical analysis
Statistical analysis were performed using Prism version 5.02 (GraphPad Software, La Jolla, CA, USA). Non-parametric tests were used for the statistical analysis. The MannWhitney U-test was performed to compare unpaired groups of variables and the KruskalWallis test to compare continuous variables with nominal variables with more than two levels. The Spearman rank correlation test was used to search for any relationships between variables, along with linear regression tests. P < 0.05 was considered statistically significant. The results are reported as mean along with S.D.
Results
BMD was significantly lower in both SSc and RA patients than in the control group (P < 0.001) (see Table 2 ). No significant difference was observed in the mean lumbar spine BMD between patients with SSc and RA (P = 0.238).
Lumbar spine TBS was significantly lower in SSc and RA patients than in the control group [respectively, 1.032 (0.163) and 0.904 (0.148) vs 1.361 (0.126), both P < 0.001]. There was no statistically significant difference in mean lumbar spine TBS between patients with SSc and those with RA (P = 0.238). It is noteworthy that the TBS values in the scleroderma patients correlated positively with the values of the measured BMD at the level of the spine (P = 0.04), femoral neck (P < 0.01) and whole femur (P < 0.01).
When the three categories of capillaroscopic patterns were compared for the SSc patients, it was observed that the TBS values were lower in the group of patients with a late pattern, compared with the groups with an active or early pattern (late vs active and early pattern, P < 0.001). Interestingly, there was no statistically significant difference in the BMD values, measured on the column, femoral neck and whole femur (late vs active and early pattern, P = 0.07) (see Table 3 ).
Serum levels of 25(OH)D were statistically significantly lower in patients with SSc than in the control group [14.2 (7.4) vs 32.8 (2.3) ng/ml, P < 0.001]. Bone ALP level was lower in the SSc group than in the control group [7.46 (2.06) vs 18.45 (4.51) U/l; P < 0.001]. There was a positive correlation between the TBS values and the bone ALP values (P < 0.0001) and a negative correlation with the duration in terms of years of RP in the SSc patients (P < 0.01). There was no statistically significant correlation between the TBS values and serum PTH, 25(OH)D, calcium, phosphorus or SSc disease duration in years. A statistically significant difference between the three different capillaroscopic patterns was observed in the 25(OH)D values, bone ALP and duration of RP. There was no statistically significant difference in the PTH, calcium or phosphorus serum concentrations (see Table 3 ).
There was a positive correlation between the TBS values and bone ALP values (respectively, late P = 0.002; active P = 0.003; early P = 0.004) for all three groups, while only in the late pattern group was a negative correlation observed between the TBS and SSc duration, in years, of RP (P < 0.0001). There was no correlation between the TBS values in the three groups and the BMD measured at the spine, femoral neck and level of the whole femur or between the vitamin D values.
Furthers subdividing the scleroderma patient groups into three subgroups on the basis of the presence/absence of previous vertebral fractures, this study demonstrated that 20/29 (68%) patients with previous vertebral fractures had a late pattern, 6 (21%) an active pattern and 3 (11%) an early pattern. Moreover, 44% of all the patient groups had OP and 56% osteopenia.
A total of 29 SSc patients (34%) had had a previous vertebral fracture and it was observed that all the patients with previous vertebral fracture had a low bone mass and that 13 (44%) had OP and 16 (56%) osteopenia. The TBS values were significantly lower in the subgroup of SSc patients with previous vertebral fractures than in those without fractures [0.990 (0.07) vs 1.178 (0.07); P < 0.0001]. The vitamin D values were statistically lower in the subgroup of SSc patients with previous fractures than the subgroup of patients without vertebral fractures [8.51 (12. 6) vs 17.16 (7.25) ng/ml; P < 0.0001]. The BMD measured at the spine and the whole femur were statistically significantly lower in the facture subgroup than the subgroup without fractures [respectively, column BMD 0.982 (0.16) vs 1.016 (0.14) g/cm 2 , P = 0.006; BMD femur entire 0.755 (0.13) vs 0.851 (0.12) g/cm 2 ; P = 0.0009]. [2123] . Recently it was demonstrated that bone microarchitecture plays a determinant rule in bone strength. The TBS is novel and based on an imaging technique that uses standard DXA images. Evidence to date indicates that it is an index of bone texture that provides skeletal information additional to that obtained by the standard BMD [24, 25] .
Our study confirmed that TBS, evaluated at the lumbar spine, with lumbar and femoral BMD, is able to discriminate patients with altered bone microstructure. The authors propose it be used as a clinical tool in the general diagnosis of OP in chronic inflammatory rheumatic diseases, such as SSc and RA, in line with other reports [4, 5, 35] . Although there are other imaging techniques able to provide direct information on trabecular bone microarchitecture, for example magnetic resonance and CT, these are not simple to use in routine practice since they are expensive and not always available and can examine only peripheral area bone.
Bone damage may have multi-factorial underlying causes: disability, age, longstanding diseases, a low BMI, chronic systemic inflammation, low vitamin D levels and some treatment regimes [612] . In SSc patients, the presence of lower serum 25(OH)D levels than those observed in the control groups and the fact that it is lower in late pattern patients than in active or early ones may be related to a reduced vitamin D intestinal absorption [7, 8, 1012] .
Furthermore, the 25(OH)D value correlated with TBS but not with BMD, as already observed by Koumakis et al. [35] . These data confirmed that the two techniques evaluated different aspects of bone and that they may be used together to enhance evaluation of bone damage. Moreover, there were statistically significant lower ALP levels in SSc patients than in the control group. It is noteworthy that this value was lower in patients with a late pattern than in those with an active or early one, with a probable correlation to a reduced bone turnover and bone neoformation [36] .
Finally, it was demonstrated that there is a negative correlation between the reduced bone microarchitecture, evaluated by TBS, and the progression of microvascular damage, studied by NVC; this observation suggests that the microvascular damage is correlated with systemic SSc clinical complications, including bone impairment [3740] .
A limitation to the present study might be that the number of subjects was not identical in all groups, due to a single centre recruitment and the use of exclusion criteria. However, the total sample size was considered sufficient. Moreover, almost 70% of the RA cases were treated with low dose glucocorticoids (<5 mg prednisone/ day) but we have no data as to the patients' cumulative prednisone dosage.
In conclusion, this study confirmed that TBS (and BMD) may well represent a complementary tool for the evaluation of bone quality and the risk of fracture in various diseases, as well as in SSc patients [18, 35, 4143] . The bone quality seems lower in SSc patients with more altered microcirculation (NVC patterns). Therefore, TBS may represent a further marker to estimate the general clinical status in chronic rheumatic diseases at least in SSc. 
